Product Information
AVAPRO 150 MG TABLET is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $7.3449 per EA under NDC 00024585130. Its NADAC has been published 639 times since Nov 28, 2013.
FDA first approved this application on Sep 30, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the irbesartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024585130
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IRBESARTANApproval Type
New Drug (NDA)
FDA Application
NDA020757FDA Approved
9/30/1997
TE Code
AB
On Market Since
1/1/2013
Pharmacological Classes
Price Statistics
The NADAC for AVAPRO 150 MG TABLET has been published 639 times since Nov 28, 2013, and over the history we have for it it has risen 115.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.3449 per EA |
|---|---|
| All-time high | $7.3655 (Jun 10, 2026) |
| All-time low | $3.4028 (Nov 28, 2013) |
| 52-week high | $7.3655 |
| 52-week low | $7.3323 |
| Median price | $6.3687 |
| Average price | $6.1480 |
| Largest weekly change | +10.0% (Oct 14, 2015) |
| Weeks tracked | 639 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the irbesartan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AVAPRO 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AVAPRO 150 MG TABLET, manufactured by Sanofi-Aventis U.S. LLC, is $7.3449 per EA (NDC 00024585130), effective Aug 19, 2026.
How has the price of AVAPRO 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for AVAPRO 150 MG TABLET has risen 115.8%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AVAPRO 150 MG TABLET?
Since Nov 28, 2013, the NADAC for AVAPRO 150 MG TABLET has ranged from a low of $3.4028 (Nov 28, 2013) to a high of $7.3655 (Jun 10, 2026), with a median of $6.3687 per EA.
Are there cheaper alternatives to AVAPRO 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of AVAPRO 150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AVAPRO 150 MG TABLET?
AVAPRO 150 MG TABLET (NDC 00024585130) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.